Sarcoma  >>  CD Protein Inhibitors 


12»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 0112233445566778899110
            
            
             
sunitinib / Generic mfg.           
          
            
             
Keytruda (pembrolizumab) / Merck (MSD)           
          
            
             
Opdivo (nivolumab) / BMS           
          
            
             
Tecentriq (atezolizumab) / Roche           
          
            
             
AiRuiKa (camrelizumab) / HLB Bio Group           
          
            
             
Imfinzi (durvalumab) / AstraZeneca           
          
            
             
Ibrance (palbociclib) / Pfizer           
          
            
             
Bavencio (avelumab) / EMD Serono           
          
            
             
Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap           
          
            
             
Tevimbra (tislelizumab-jsgr) / BeiGene           
          
            
             
Kisqali (ribociclib) / Novartis           
          
            
             
Tyvyt (sintilimab) / Eli Lilly           
          
            
             
Jemperli (dostarlimab-gxly) / GSK           
          
            
             
Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci           
          
            
             
Verzenio (abemaciclib) / Eli Lilly           
          
            
             
Libtayo (cemiplimab-rwlc) / Regeneron           
          
            
             
Kaitanni (cadonilimab) / Akesobio           
          
            
             
Enweida (envafolimab) / 3DMed, Tracon Pharma, Ascletis           
          
            
             
Zynyz (retifanlimab-dlwr) / Incyte           
          
            
             
bintrafusp alfa (M7824) / EMD Serono           
          
            
             
spartalizumab (PDR001) / Novartis           
          
            
             
AiRuiKang (dalpiciclib) / Jiangsu Hengrui Pharma           
          
            
             
Anniko (penpulimab) / Akesobio, Sino Biopharm           
          
            
             
Rituxan (rituximab) / Roche           
          
            
             
balstilimab (AGEN2034) / Agenus           
          
            
             
socazolimab (STI-A1014) / Sorrento           
          
            
             
Cosela (trilaciclib) / G1 Therap           
          
            
             
Yutuo (zimberelimab) / Arcus Biosci, Gilead           
          
            
             
alvocidib (DSP-2033) / Sumitomo Pharma           
          
            
             
bempegaldesleukin (NKTR-214) / Nektar Therap, BMS, Ono Pharma           
          
            
             
Omblastys (131I-omburtamab) / Y-mAbs Therap           
          
            
             
Promacta (eltrombopag) / Novartis           
          
            
             
SCRI-CARB7H3(s)x19 / Seattle Children's Hospital           
          
            
             
T3011 / ImmVira Pharma           
          
            
             
benmelstobart (APL-502) / Apollomics           
          
            
             
ezabenlimab (BI 754091) / Boehringer Ingelheim           
          
            
             
izuralimab (XmAb23104) / Xencor           
          
            
             
pepinemab (VX15) / Vaccinex           
          
            
             
sasanlimab (PF-06801591) / Pfizer           
          
            
             
Aibining (geptanolimab) / Apollomics           
          
            
             
Arenegyr (NGR-hTNF) / AGC Biologics           
          
            
             
Blincyto (blinatumomab) / Astellas, Amgen           
          
            
             
CDX-1140 / Celldex           
          
            
             
Campath (alemtuzumab) / Sanofi           
          
            
             
EGFR bi-armed autologous activated T cells / Barbara Ann Karmanos Cancer Institute           
          
            
             
GI-101 / GI Innovation           
          
            
             
LAE005 / Laekna Therap           
          
            
             
MK-4830 / Merck (MSD)           
          
            
             
Mylotarg (gemtuzumab ozogamicin) / UCB, PDL, Pfizer           
          
            
             
NY-ESO-1 TCR-T cell therapy / Gilead           
          
            
            


12»